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Abstract
Background: This study aimed to assess cardiac and pulmonary pathophysiological responses during cooling and
extracorporeal life support (ECLS) rewarming in a porcine model of deep hypothermic cardiac arrest (DHCA). In
addition, we evaluated whether providing a lower flow rate of ECLS during the rewarming phase might attenuate
cardiopulmonary injuries.
Methods: Twenty pigs were cannulated for ECLS, cooled until DHCA occurred and subjected to 30 min of cardiac arrest.
In order to assess the physiological impact of ECLS on cardiac output we measured flow in the pulmonary artery using
Doppler echocardiography as well as a modified thermodilution technique using the Swan-Ganz catheter (injection site in
the right ventricle). The animals were randomized into two groups during rewarming: a group with a low blood flow rate
of 1.5 L/min (LF group) and a group with a normal flow rate of 3.0 L/min (NF group). The ECLS temperature was adjusted
to 5 °C above the central core. Cardiac output, hemodynamics and pulmonary function parameters were evaluated.
Results: During the cooling phase, cardiac output, heart rhythm and blood pressure decreased continuously.
Pulmonary artery pressure tended to increase at 32 °C compared to the initial value (20.2 ± 1.7 mmHg vs. 29.1 ± 5.
6 mmHg, p = 0.09). During rewarming, arterial blood pressure was higher in the NF than in the LF group at 20° and
25 °C (p = 0.003 and 0.05, respectively). After rewarming to 35 °C, cardiac output was 3.9 ± 0.5 L/min in the NF group vs.
2.7 ± 0.5 L/min in LF group (p = 0.06). At the end of rewarming under ECLS cardiac output was inversely proportional
to the ECLS flow rate. Moreover, the ECLS flow rate did not significantly change pulmonary vascular resistance.
Discussion: Using a newly developed experimental model of DHCA treated by ECLS, we assessed the cardiac and
pulmonary pathophysiological response during the cooling phase and the ECLS rewarming phase. Despite lower
metabolic need during hypothermia, a low ECLS blood flow rate during rewarming did not improved cardiopulmonary
injuries after rewarming.
Conclusion: A low ECLS flow rate during the rewarming phase did not attenuate pulmonary lesions, increased blood
lactate level and tended to decrease cardiac output after rewarming. A normal ECLS flow rate did not increase
pulmonary vascular resistance compared to a low flow rate. This experimental model on pigs contributes a number of
pathophysiological findings relevant to the rewarming strategy for patients who have undergone accidental DHCA.
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Background
Hypothermia by reducing body temperature and there-
fore the body’s metabolism induces a series a physio-
logical changes to homoeothermic organisms. The initial
response to cold exposure is to generate body heat
through shivering, a sympathetic response with vasocon-
striction, increased oxygen consumption as well as heart
and respiratory rate, stroke volume and cardiac output
[1]. After this initial phase, the decrease of total body
metabolism is proportional to the level of hypothermia.
Respiratory rate, as well as heart rate, arterial blood
pressure and cardiac output decrease to about 50 % of
the normothermic level at 28 °C and about 20 % at 20 °C
in laboratory animal and human models [2–4]. Below
28 °C, cardiac arrhythmias are frequent and onset of
ventricular fibrillation is the main cause of death in
patients suffering accidental hypothermia [1, 5–9].
The cardioprotective and neuroprotective effects as
well as the limitation of ischemia/reperfusion injuries
mediated by hypothermia are widely used in cardiac sur-
gery and in the treatment of several conditions such as
postcardiac arrest syndrome, traumatic brain injury and
neonatal anoxia [10].
In case of accidental hypothermia with hemodynamic
instability or cardiac arrest, extracorporeal life support
(ECLS) is the preferred method of rewarming because it
can provide sufficient circulation and oxygenation while
the core body temperature can be managed by control-
ling the blood temperature [6, 9]. Most of the physio-
logical data available on ECLS rewarming were obtained
in the context of cardiac surgery.
Femoral arteriovenous cannulation is the method of
choice for ECLS rewarming [5, 11]. The venous cannula
withdraws blood at the level of the right atrium/vena
cava, therefore decreasing right ventricular volume; then
oxygenated blood is reinjected in the femoral artery with
a retrograde flow. During the ECLS rewarming phase
after deep hypothermic cardiac arrest (DHCA) severe
cardiopulmonary dysfunction including severe pulmon-
ary edema and adult respiratory distress syndrome have
been frequently reported [9, 11]. These complications
can be partly explained by ischemia/reperfusion injuries
but can also be aggravated by the rewarming strategies
[11–13]. On isolated lungs, the flow provided by the
pump in the pulmonary artery needs to be reduced com-
pared to theoretical normal cardiac output. Several stud-
ies have demonstrated in ex vivo rodent lungs that
pulmonary edema was reduced with reduced flow rate
[14, 15]. It is recommended to adjust the flow rate to
maintain pulmonary artery pressure between 15 and
20 mmHg in order to limit capillary-alveolar membrane
lesions [16].
The aim of this study was to assess the impact of
ECLS flow rate on cardiac and pulmonary responses
during the rewarming phase after DHCA in a porcine
model. In addition, our experimental model of accidental
hypothermia allowed us to describe the pathophysio-
logical response during the cooling phase until DHCA.
Methods
Study design and setting
Animal experiments were carried out in accordance with
the relevant French and European Community regula-
tions. All protocols were approved by the Centre de
Recherche du Service de Santé des Armées Institutional




Female Yorkshire pigs, weighing 43.6 ± 0.9 kg, were
fasted overnight. Initial sedation was achieved with
intramuscular administration of tiletamine and zolaze-
pam (12.5 mg/kg) followed by inhaled isoflurane 2 %. A
20-gauge catheter was placed in an ear vein. The pigs
were then curarized with 1.5 mg/kg of intravenous ad-
ministration of suxamethonium chloride, intubated and
mechanically ventilated with isoflurane 2 % to maintain
anesthesia. The tidal volume was set at 8 mL/kg with a
50 % inspired oxygen fraction (FiO2) and the respiratory
rate was adjusted to maintain PaCO2 at 40 mmHg. A 5-
F Swan-Ganz catheter (Edward Lifesciences, Maurepas,
France) was placed in the pulmonary artery, and a 5-F
arterial catheter was placed in the right carotid artery.
In addition, a 20-F femoral vein catheter and a 12-F
femoral artery catheter (Edwards Lifesciences, Irvine,
CA, USA) were inserted using an ultrasound-guided per-
cutaneous approach. Standard cardiopulmonary bypass
equipment was used: centrifugal pumps (Cobe Century,
Arvada, CO, USA) and a heat exchanger (Sarns Inc.,
Ann Arbor, MI, USA), a membrane oxygenator (Sorin
Group; Munich, Germany), non-heparin-bonded circuit
tubing and tank. The tank was primed with 0.5 L of
NaCl 0.9 % solution. Heparin (300 units/kg) was injected
intravenously just before cannulation.
Surface electrocardiographic tracings were continu-
ously recorded. All hemodynamic data including aortic
pressure, pulmonary artery pressure, blood oxygen satur-
ation and end-tidal CO2 were continuously monitored
and recorded with a digital recording system (BIOPAC
MP 150, BIOPAC Systems, Inc., Goleta, CA, USA).
Cardiac outputs were measured with the thermodilu-
tion technique using the Swan-Ganz catheter. To allow
accurate measurement during ECLS, the injection site of
the 5-F Swan-Ganz catheter was located in the right
ventricle and the sampling site in the pulmonary artery
[17]. An average of at least three measurements of car-
diac output that agreed within 10 % was used.
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Core temperature was measured using the Swan-Ganz
thermistor and with an esophageal probe. Return of
spontaneous circulation (ROSC) was defined using the
Utstein guidelines for uniform reporting in animal re-
search [18].
Arterial blood gases (Gem 3000, Instrumentation
Laboratory, Bedford, MA, USA) were obtained at base-
line, then at 30 °C, 25 °C, 20 °C and after 30 min of un-
treated cardiac arrest at the beginning of the rewarming
phase, and then during the rewarming phase at 25 °C,
28 °C, 30 °C, 35 °C and 30 min after 35 °C was reached.
Protocol
Cooling phase Hypothermic cardiac arrest was induced
using external cold packs (Colpac, Chattanooga group,
Chattanooga, TN, USA) associated with ECLS at a very
low flow rate of 7 mL/min/kg at 4 °C. To simulate the
physiological decrease in respiratory rate during the cool-
ing phase, the isoflurane concentration and respiratory
rate were adjusted to the central temperature (respect-
ively, 1.5 % and 15/min <30 ° C, 1 % and 10/min < 25 °C).
Cisatracurium besilate 0.15 mg/kg was injected intraven-
ously to induce and maintain curarization. When DHCA
occurred (defined by an absence of arterial pressure
pulse), ECLS and respiratory support were stopped and
the animals were kept for 30 min in untreated cardiac ar-
rest (ischemic period).
Rewarming phase After 30 min of full ischemic state, a
total of 20 pigs were distributed according to a preestab-
lished randomization table into two different groups
with different ECLS rewarming flow rates (n = 10 per
group): the LF group with a flow rate of 1.5 L/min
(≈35 ml/kg/min) and the NF group with a flow rate of
3 L/min (≈70 mL/kg/min). The temperature in the
extracorporeal circuit was adjusted to 5 °C above the
central core temperature in all groups. When a central
core temperature of 28 °C was reached, external
defibrillation was attempted. Two hundred joules external
shock was delivered every 2 min until ROSC was achieved.
If necessary, after three unsuccessful defibrillations and
central temperature above 32 °C, a bolus of 0.5 mg of epi-
nephrine every 4 min and one 150-mg bolus of amioda-
rone were added until ROSC was achieved. The isoflurane
concentration and respiratory rate were adjusted depend-
ing on the central temperature with the reverse setting of
the cooling phase. After achieving ROSC, the rewarming
strategy was continued until the body temperature
reached 35 °C. Then final hemodynamic measurements
were taken and cardiac function was assessed under
different ECLS flow rates: the initial rewarming rate
(1.5 or 3 L/min according to randomization group), a
standardized low flow rate of 1 L/min and finally the
ECLS pump was stopped.
The protocol key points are summarized in Fig. 1.
Measurements
Hemodynamic measurements
Except during the rewarming phase before ROSC and at
the end of the experiment to access the specific ECLS
impact on hemodynamics at different flow rates, all the
measurements (cardiac output, systolic and pulmonary
arterial pressures) were recorded after stopping the
pump of the extracorporeal circuit for 2 min.
Pulmonary vascular resistance (PVR) was calculated as
follows:
PVR
¼ mean pulmonary arterial pressure−mean pulmonary artery wedge pressureð Þ
cardiac output
Doppler echocardiographic evaluation of right cardiac
output
In order to have an external validation of the modified
thermodilution technique, a transthoracic echocardio-
gram was obtained on the last five pigs included in each
group (n = 10). Cardiac output measurements were
Fig. 1 Different phases of the study protocol. ROSC: return of spontaneous circulation, ECLS: extracorporeal life support. * Settings of the ECLS
were randomized into two groups: LF, low blood flow rate of 1.5 L/min; NF, normal blood flow rate of 3 L/min. The temperature in the
extracorporeal circuit was adjusted to 5 °C above the central core temperature in both groups
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performed at baseline, during the cooling phase at 32 °C,
30 °C, 25 °C and during the rewarming phase at 30 °C
and 35 °C with different ECLS flow settings (initial
rewarming flow rate (1.5 or 3 L/min), 1 L/min and ECLS
stopped). Right cardiac output was computed from the
pulmonary artery diameter and the velocity time integral
obtained from a parasternal view (Fig. 2).
Markers of lung injury
The lung capillary-alveolar permeability to the macro-
molecule (FITC-Dextran70) was measured by broncho-
alveolar lavage (BAL) at the end of the experiment. This
method was developed in our laboratory and was previ-
ously described and validated in detail [19, 20]. Briefly, we
intravenously administered a macromolecular indicator of
fluorescein isothiocyanate-labeled dextran (FITC-D70)
(Sigma; St. Quentin Fallavier, France). After 25 min, a BAL
was performed with 100 mL of a saline solution at 0.9 %
with 5 g of albumin. Thirty minutes after administration
of the FITC-D70 and 5 min after BAL, we measured
FITC-D70 concentrations in both the blood and the BAL
fluid, with a fluorescence spectrophotometer (NanoDrop
ND-3300 by Labtech; Palaiseau, France). The FITC-D70
transport rate coefficient KAB (min
−1) (coefficient of per-
meability of the capillary-alveolar membrane) from blood
to alveoli was then estimated by KAB = ([FITC-D70] in
BAL/[FITC-D70] in blood)/30.
Distal alveolar fluid clearance (AFC) was measured as
previously described. Briefly, following the stabilization
period, a catheter (PE 240 tubing; BD; Franklin Lakes,
NJ, USA) was passed through a side port in the endo-
bronchial tube into the lung and advanced until gentle
resistance was encountered. Then 150 mL of warmed
(36 °C) normal saline containing 5 % bovine serum albu-
min was instilled through the catheter into the airspaces
of the lung. After 5 min (T = 0) and 35 min (T = 30 min),
samples were removed through the catheter by gentle as-
piration. The change in protein concentration at T =
30 min was used to determine the volume of fluid cleared
from the airspaces with the following equation:
Distal AFC %=hð Þ ¼ 2 1 ‐ T0 concentration=T30 concentrationð Þð Þ
At the end of the experiments, animals were eutha-
nized with intravenous KCL and a segment of the nonla-
vaged lung was excised and frozen for measurement of
the wet-to-dry weight (W/D) ratio. The W/D ratio
was determined by drying the lung segments in an
oven (60 °C) and then a constant weight was mea-
sured over 1 week.
Biomarkers
A 3-mL sample of arterial blood was drawn at baseline
and at the end of the experiment. Blood samples were
centrifuged immediately for 15 min at 2000 g at 4 °C. The
plasma and BAL samples were then stored at −80 °C
until batch-wise analysis. Blood concentrations of pro-
inflammatory cytokines, interleukin 1β (IL-1β), IL-6,
IL-10 and tumor necrosis factor α (TNF-α) were de-
termined using Biochip Array Technology (Randox
Laboratories Ltd, Antrim, United Kingdom).
The blood concentrations of the receptor for advanced
glycation end products (RAGEs) were determined using
an enzyme-linked immunosorbent assay kit (Clinis-
cienses, France). RAGEs are a multiligand receptor of
the immunoglobulin superfamily of cell surface mole-
cules that acts as a pattern-recognition receptor. RAGEs
were initially identified in the lung tissue, which has the
highest basal level of expression under normal condi-
tions and is relatively specific to alveolar epithelial cell
injury [21, 22].
Fig. 2 Representative arterial and pulmonary pressure measurement over time during the cooling phase
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Data analysis
Values are presented as mean ± standard error of the
mean (SEM). Categorical variables were compared using
the Fisher exact test. The Student t-test or Mann–
Whitney nonparametric test was used to compare quanti-
tative values between groups. To compare biomarker re-
sults between groups and between baseline and endpoint
measurement, two-way factorial ANOVA for repeated
measures was used. Correlation and agreement analyses
were done between right cardiac output measured by
thermodilution and Doppler echocardiography with the
correlation scatter plot, the Pearson correlation method,
and the Bland-Altman diagram. All reported p-values are
two-sided. Significance was defined as p < 0.05. Statistical
analyses were performed using SPSS software, version 22
(IBM SPSS Statistics, Armonk, NY, USA).
Results
There were no significant baseline differences between
treatment groups (Table 1).
Cooling phase
During the cooling phase, cardiac output, heart rate and
mean arterial pressure decreased continuously (p < 0.001
for linear trend). The heart rate and arterial pressure
were 96 ± 8 % and 117 ± 16 % of basal value at 32°, 68 ±
4 % and 69 ± 8 % at 30°, 54 ± 4 % and 59 ± 7 % at 25 °C
and 27 ± 7 % and 24 ± 4 % at 20 °C, respectively (Fig. 2)
(p < 0.001 for linear trend). The mean pulmonary artery
pressure tended to increase at 32 °C compared to base-
line (20.2 ± 1.7 mmHg vs. 29.1 ± 5.6 mmHg, p = 0.09)
and then decreased with core temperature (21.7 ±
1.9 mmHg, 17.4 ± 1.5 mmHg and 13.5 ± 2.4 mmHg at
30, 25 and 20 °C, respectively) (Figs. 2 and 3) (p < 0.001
for linear trend). Overall, pulmonary arterial resist-
ance increased with cooling initiation and remained
higher than baseline value (262 ± 37, 475 ± 72 and
481 ± 86 dyn · s · cm−5 at baseline, 30 and 25 °C, re-
spectively; p = 0.03); there was no difference between
groups (p = 0.34).
Cardiac arrest occurred at 19.4 ± 0.6 °C and there were
no differences between groups (p = 0.93). Six animals
Table 1 Characteristics according to randomization group during the cooling and ECLS rewarming phase
Cooling phase ECLS rewarming phase
Baseline 32 30 25 20 20 25 30 35
LF group HR, beats/min 100 ± 5 84 ± 9 70 ± 5 55 ± 4 29 ± 9 88 ± 15 124 ± 6
AP, mmHg 72 ± 7 70 ± 4 44 ± 4 29 ± 2 19 ± 4 27 ± 3* 35 ± 3* 70 ± 9 63 ± 8
PAP, mmHg 20 ± 2 28 ± 7 24 ± 3 19 ± 3 13 ± 2 8 ± 1 11 ± 2 19 ± 3 33 ± 3
PVR, dyn · s · cm−5 234 ± 50 487 ± 132 515 ± 139 800 ± 419 951 ± 229
EtCO2, mmHg 42 ± 4 27 ± 1 29 ± 1.3 24 ± 2 23 ± 1 11 ± 2 5 ± 1 16 ± 3 33 ± 3
CO, L/min 4.4 ± .4 3.3 ± .4 2.8 ± .3 2.3 ± .5 1.4 ± .3& 2.7 ± .5
pH 7.40 ± .02 7.43 ± .02 7.39 ± .03 7.35 ± .04 7.18 ± .02 7.28 ± .04 7.36 ± .06 7.35 ± .05 7.38 ± .04
PO2/FiO2, mmHg 449 ± 40 598 ± 69 547 ± 68 549 ± 74 523 ± 191 386 ± 78 934 ± 145 480 ± 118 398 ± 123
PCO2, mmHg 51 ± 3 40 ± 2 46 ± 3 49 ± 5 56 ± 10 54 ± 6 47 ± 6 43 ± 5 37 ± 3
Serum lactate, mmol/L 2.09 ± .21 7.66 ± 1.55 5.44 ± .54*
Serum potassium, mmol/L 3.87 ± .15 3.97 ± .13 3.77 ± .17
NF group HR, beats/min 107 ± 9 80 ± 6 68 ± 6 51 ± 5 25 ± 10 91 ± 9 138 ± 9
AP, mmHg 68 ± 3 66 ± 5 46 ± 5 28 ± 3 20 ± 1 41 ± 3* 48 ± 3* 64 ± 6 74 ± 7
PAP, mmHg 21 ± 3 32 ± 15 20 ± 2 16 ± 2 15 ± 6 11 ± 1 12 ± 1 18 ± 3 29 ± 3
PVR, dyn · s · cm−5 287 ± 55 461 ± 54 453 ± 121 480 ± 208 499 ± 93
EtCO2, mmHg 42 ± 4 25 ± 4 26 ± 2 22 ± 2 19 ± 3 11 ± 2 7 ± 2 12 ± 3 30 ± 4
CO, L/min 4.4 ± .4 3.0 ± .4 2.5 ± .2 1.9 ± .1 1.7 ± .6& 3.9 ± .5
pH 7.40 ± .02 7.45 ± .14 7.41 ± .04 7.38 ± .03 7.34 ± .01 7.33 ± .03 7.27 ± .03 7.37 ± .03 7.39 ± .03
PO2/FiO2, mmHg 433 ± 52 514 ± 164 574 ± 51 684 ± 85 369 ± 45 344 ± 35 783 ± 158 755 ± 103 382 ± 59
PCO2, mmHg 49 ± 3 43 ± 16 43 ± 4 46 ± 3 48 ± 3 52 ± 5 51 ± 3 38 ± 3 33 ± 3
Serum lactate, mmol/L 2.27 ± .20 5.30 ± .86 3.91 ± .50*
Serum potassium, mmol/L 3.96 ± .08 3.99 ± .16 3.76 ± .17
Groups: LF/low blood flow rate of 1.5 L/min; NF/normal blood flow rate of 3 L/min. PaO2/FiO2 arterial oxygen pressure/inspired oxygen fraction, ABP arterial blood
pressure, PAP pulmonary arterial pressure, PVR pulmonary vascular resistance. Values are presented as mean ± SEM. & measured only on 6 pigs in each group that
achieved ROSC at this time point. * p < 0.05 compared with the other group
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developed ventricular fibrillation, 11 animals presented
asystole, and three animals pulseless electrical activity.
At the end of 30 min of untreated cardiac arrest, all
pigs were in asystole.
Rewarming phase
After the beginning of the rewarming phase, the time to
reach 30 °C was 43 ± 5 vs. 35 ± 3 min (p = 0.19) and
the time to reach 35 °C was 105 ± 18 and 74 ± 8 min
(p = 0.14) in the LF and NF groups, respectively.
Hemodynamics and respiratory parameters during the
rewarming phase are presented in Table 1. Mean arterial
pressure and mean pulmonary arterial pressure in-
creased continuously during the rewarming phase with
core temperature (p < 0.001 for linear trend in both
groups).
Before ROSC, the mean arterial pressure on ECLS
during the rewarming phase was higher in the NF group
than in the LF group at 20 °C and 25 °C (p = 0.003 and
0.05, respectively).
The mean number of external defibrillations used
(3.1 ± 0.7 vs. 2.9 ± 0.6) and adrenaline injected intraven-
ously (0.2 ± 0.08 mg in both groups) to achieve ROSC did
not differ between groups (p = 0.82 and p = 0.72, respect-
ively). All animals were successfully resuscitated: the mean
temperature at ROSC was 30.5 ± 0.5 °C in the LF group
vs. 30.6 ± 0.7 °C the NF group (p = 0.84).
At the end of the rewarming phase, at 35 °C, after the
ECLS pump stopped, cardiac output tended to be higher
in the NF group than in the LF group: 3.9 ± 0.5 vs. 2.7 ±
0.5 L/min (p = 0.06). The serum lactate level at the end
of rewarming was higher in the LF group than in the NF
group (p = 0.04).
ECLS impact on hemodynamic and doppler
echocardiographic measurements
At the end of the rewarming phase, the hemodynamic
and respiratory parameters with the ECLS inflow rate
set at the initial randomization rate (3 or 1.5 L/min), at
1 L/min or stopped are presented in Table 2.
EtCO2 (p = 0.01 for linear trend), right cardiac output
measured by thermodilution (p = 0.001 for linear trend)
and right cardiac output measured with Doppler echo-
cardiography (p = 0.01 for linear trend) were inversely
proportional to the ECLS flow rate.
Compared with the thermodilution technique, right
cardiac output measurement with Doppler echocardiog-
raphy had a bias of −0.04 L/min (limit of agreement ±
1.1) (Fig. 3). Including the measurement only when the
ECLS pump was running at the end of the rewarming
phase, bias was −0.02 L/min (limit of agreement ± 1.1 L/
min). The correlation coefficient was r = 0.74 (p < 0.001)
for all measurements (Fig. 3) and r = 0.72 (p = 0.001) for
measurements with the ECLS pump running at the end
of the rewarming phase.
FITC-D70 transport rate coefficient KAB, wet-to-dry weight
ratio and alveolar fluid clearance
The coefficient of permeability of the capillary-alveolar
membrane was high in the LF and NF groups: 4.6 ± 1.1
vs. 5.5 ± 1.4 10−4.min−1, respectively (p = 0.63). Distal al-
veolar fluid clearance was decreased with 7.7 ± 0.3 and
6.4 ± 0.01 % per hour for the LF and NF groups, respect-
ively (p = 0.74). The W/D weight ratio did not differ
between groups: 6.6 ± 0.1 for the LF group and 6.4 ± 0.3
for the NF group (p = 0.51).
Fig. 3 a Bland-Altman plot, difference vs. the average right cardiac output measured by thermodilution compared to the Doppler echocardiography
method (L/min), b Correlation between right cardiac output measured by the thermodilution and the Doppler echocardiography method. CO, cardiac
output, r, Pearson correlation coefficient
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Biomarkers
The serum IL-1β, IL-6, TNF-α and RAGE concentra-
tions at baseline and at the end of the experiment are
presented in Fig. 4. There was a significant variation be-
tween baseline and endpoint for all cytokines. There was
no significant variation of cytokine concentrations be-
tween groups (Fig. 4).
Discussion
Using a newly developed experimental model of deep
hypothermic cardiac arrest treated by ECLS [23], we
assessed the cardiac and pulmonary pathophysiological
response during the cooling phase and the ECLS
rewarming phase. A lower ECLS flow rate during the
rewarming phase did not attenuate pulmonary lesions,
increased the serum lactate level and tended to impair
cardiac output after rewarming. Moreover, ECLS at a
normal flow rate during rewarming did not increase pul-
monary vascular resistance compared to an ECLS at a
low flow rate.
In contrast to isolated ex vivo lung models in which a
reduced inflow rate in the pulmonary artery was associ-
ated with a decrease in the pulmonary edema rate [14,
16], reducing the inflow ECLS rate in our model did not
attenuate pulmonary lesions. In a porcine model of ex
vivo lungs, pulmonary artery inflow with only 40 % of
the theoretical cardiac output value was associated with
good viability for 12 h and good results after transplant-
ation [24]. The increased permeability of blood vessels
after ischemia/reperfusion injury is increased by any
variation of pressure and therefore facilitates liquid ex-
travasation. In ex vivo models, increased inflow pressure
led to an immediate increase of pulmonary artery and ca-
pillary pressure [16, 24]. This increase put some lung terri-
tories under pressure, which had first been collapsed by
the protective mechanism associated with hypoxic pul-
monary vasoconstriction and hypothermia. In our model,
rewarming ECLS generates a systemic blood flow while
providing a decrease in right ventricle volume (seen in the
present results with the decrease of right cardiac output ac-
cording to the ECLS flow rate). It has been demonstrated
in a human lung model that rewarming after deep
hypothermia was associated with vasoconstriction in pul-
monary arteries and increased resistance. Nevertheless,
after complete rewarming, pulmonary arteries recovered a
normal tone similar to that before hypothermia [25]. A de-
creased volume in the pulmonary circulation under ECLS
could limit the increase of PVR and pulmonary artery pres-
sure and thus could provide a benefit to limit pulmonary
lesions. In 59 patients, Ruttman et al. found a decrease in
the pulmonary edema rate using femorofemoral ECLS
compared to cardiopulmonary bypass [11]. While the
ROSC rate was similar in both groups, patients treated
with cardiopulmonary bypass were weaned faster due to
more hemolysis and systemic inflammation. In contrast,
using femorofemoral ECLS, circulatory support lasting sev-
eral days is possible, allowing time for the myocardium and
respiratory function to recover before weaning [26, 27].
Since ECLS affects the right and left heart differently,
its hemodynamic impact is difficult to analyze without
Table 2 Hemodynamic parameters with or without ECLS at 30 °C during the cooling phase and at 35 °C at the end of the
rewarming phase
35 °C ECLS 3 L/min 35 °C ECLS 1.5 L/min 35 °C ECLS 1 L/min 35 °C no ECLS
LF group HR, beats/min 121 ± 3 117 ± 4 124 ± 6
AP, mmHg 64 ± 3* 69 ± 4 63 ± 8
PAP, mmHg 31 ± 6 35 ± 4 33 ± 3
PVR, dyn · s · cm−5 612 ± 65 1268 ± 648 922 ± 411
EtCO2, mmHg 27 ± 7 31 ± 5 33 ± 3
Right CO, L/min 2.3 ± .8 2.5 ± .6 3.3 ± .8
Right CO echo, L/min 3.0 ± 1.1 2.6 ± .7 3.7 ± .8
NF group HR, beats/min 119 ± 9 128 ± 11 138 ± 9
AP, mmHg 91 ± 6* 80 ± 8 73 ± 7
PAP, mmHg 26 ± 4 31 ± 3 29 ± 3
PVR, dyn · s · cm−5 481 ± 74 538 ± 69 456 ± 61
EtCO2, mmHg 27 ± 3 33 ± 3 30 ± 4
Right CO, L/min 2.8 ± .8 3.2 ± .6 4.4 ± .5
Right CO echo, L/min 3.5 ± 1.0 3.4 ± 1.0 4.6 ± 1.0
Groups: LF/low blood flow rate of 1.5 L/min; NF/normal blood flow rate of 3 L/min. ECLS extracorporeal life support, HR heart rate, AP arterial pressure, PAP
pulmonary arterial pressure, PVR pulmonary vascular resistance, CO cardiac output
Values are presented as mean ± SEM. Results are presented for the ten pigs with right cardiac output measurement using the Doppler echocardiography method.
* p < 0.05 compared with the other group
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decoupling pulmonary and systemic circulation. In pa-
tients with left ventricular function preserved, pressure
in the left atrium is decreased by ECLS, while it increases
when left ventricular function is altered. Left ventricular
overload is facilitated every time that right cardiac output
is higher than left cardiac output [28]. In other words, in
patients with severe left ventricular dysfunction, ECLS can
increase the risk of pulmonary edema [29–32].
For the systemic circulation, higher ECLS flow is re-
lated to higher arterial pressure during rewarming. After
ROSC, post-charge is increased with higher ECLS flow
and global cardiac output depends on ECLS flow and
cardiac output [33].
Thermodilution is the reference method to measure
cardiac output [34]. However, due to the suction effect
of ECLS on right atrial blood, this method is unreliable
when ECLS is running. To remedy this problem, we
used a modified thermodilution technique validated by
Grimbert et al. positioning the injection site of the
Swan-Ganz catheter in the right ventricle [17]. They de-
scribed this method’s good validity albeit a tendency to
overestimate right cardiac output in a very low flow state
(around 20 % overestimated for right cardiac output
measured at 0.75 L/min). Despite lower reliability than
the thermodilution technique, cardiac output measure-
ment using Doppler echocardiography has been suitably
validated. The reliability of the measurement depends on
accurate positioning of the probe to measure the pulmon-
ary artery diameter [34]. The agreement in our results
between thermodilution and Doppler echocardiography
measurements confirms the inversely proportional rela-
tionship between right cardiac output and ECLS flow rate
after rewarming after DHCA.
During cooling, the heart rate, arterial pressure, and
cardiac output decreased linearly with core temperature,
as shown in previous studies [4, 35, 36]. Mean pulmon-
ary arterial pressure increased at the beginning of cool-
ing and PVR values were consistently higher than the
initial values. This increase of pulmonary arterial pres-
sure could be related to the low ECLS flow rate we used
to facilitate cooling. This effect could be similar to the
use of cold saline infusion for cooling induction in tar-
geted temperature management and could give some
insight into the increased rate of pulmonary edema de-
scribed with this cooling technique [37–40].
Despite the potential protective effect of deep
hypothermia, in this study ischemia/reperfusion injuries
and ECLS rewarming were associated with increased
permeability of the capillary-alveolar membrane and
substantial variation of proinflammatory cytokines and
markers of lung injuries. As compared with reference
values in our laboratory, lung capillary-alveolar perme-
ability to the macromolecule and distal alveolar clear-
ance were impaired [20, 22, 41, 42]. There was a trend
Fig. 4 Cytokine concentrations according to group between baseline (B) and endpoint (E) * IL-1β concentration significantly increased between
baseline and endpoint (p = 0.03), no significant variation between groups (p = 0.055). & IL-6 concentration significantly increased between baseline
and endpoint (p = 0.01); no significant variation between groups (p = 0.11). § IL-10 concentration significantly increased between baseline and
endpoint (p = 0.02); no significant variation between groups (p = 0.057). £ TNF-α concentration significantly increased between baseline and endpoint
(p = 0.03); no significant variation between groups (p = 0.23). # RAGE concentration significantly increased between baseline and endpoint (p = 0.008);
no significant variation between groups (p = 0.97)
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in our results to lower variation in IL-1β and IL-10 and
a decrease in the serum lactate level at the end of
rewarming in the NF group.
From a clinical point of view, it is worth noting that if
serum potassium concentration is proposed as a triage
tool to avoid unnecessary prolonged resuscitation in
hypothermic cardiac arrest, in our study the higher potas-
sium concentration at the end of the ischemic period was
5 mmol/L [5, 43]. It is also interesting to remember, as
shown in our results, that the usual EtCO2 values used to
determine the futility of pursuing resuscitation in normo-
thermia have not been validated in the hypothermia con-
text. Because of a lower metabolism, EtCO2 decreases
proportionally with core temperature [4, 44, 45].
Limitations
Many variables in that model could have influenced reper-
fusion injuries (e.g., anesthesia, cooling rate, hypothermia
duration, rewarming). However, all animals underwent the
same procedure until the beginning of rewarming.
It is possible that hemodynamic parameters were af-
fected by the very low flow rate of the ECLS pump used
to facilitate cooling during the cooling phase. Neverthe-
less, the results in terms of heart rate, arterial pressure
and cardiac output are similar to those found in several
studies [3, 4, 46, 47]. The rewarming rate in both groups
was relatively fast (8.8 °C/h in the low flow group vs.
12.8 °C/h in the normal flow group). As previously ob-
served [23], the main determinant in rewarming rate is
the delta of temperature between core and ECLS, it is
possible that a more important difference in rewarming
rate, a longer rewarming phase or a longer duration of
ECLS support could have modified the results.
Conclusion
We assessed the cardiac and pulmonary pathophysio-
logical response during cooling and ECLS rewarming in
a porcine model of DHCA treated with ECLS.
These results suggest that a lower flow rate during the
rewarming phase of DHCA did not improve cardiac or
pulmonary outcomes. Therefore, the impact of other
parameters such as the duration of ECLS rewarming
or targeted temperature management could be fur-
ther evaluated as they affect the prognosis of DHCA
patients.
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